Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 46.2% in April

Terumo Co. (OTCMKTS:TRUMY) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,800 shares, a growth of 46.2% from the March 31st total of 2,600 shares. Based on an average daily trading volume, of 137,800 shares, the days-to-cover ratio is presently 0.0 days.

Terumo Price Performance

OTCMKTS TRUMY traded down $0.02 during trading hours on Friday, reaching $16.60. 78,817 shares of the company’s stock were exchanged, compared to its average volume of 55,827. The firm has a fifty day moving average of $21.13 and a 200-day moving average of $17.64. The company has a current ratio of 1.90, a quick ratio of 1.13 and a debt-to-equity ratio of 0.06. Terumo has a one year low of $12.56 and a one year high of $20.60. The stock has a market cap of $24.75 billion, a PE ratio of 34.99 and a beta of 0.65.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. Terumo had a net margin of 11.14% and a return on equity of 8.26%. The firm had revenue of $1.62 billion during the quarter. On average, equities research analysts predict that Terumo will post 0.57 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.